Skip Navigation

David Olayinka Kamson, M.D., Ph.D.

David Olayinka Kamson, M.D., Ph.D.

Headshot of David Olayinka Kamson
  • Assistant Professor of Oncology

Languages: English, Hungarian

Expertise

Brain Cancer, Gliomas, Metastatic Brain Tumors, Neurology, Oncology ...read more

Locations

Skip Viragh Outpatient Cancer Center

201 N. Broadway
Baltimore, MD 21287 map
Phone: 410-955-8895

Background

Titles

  • Assistant Professor of Oncology
  • Assistant Professor of Neurology

Departments / Divisions

Education

Degrees

  • MD; University of Pecs Medical School (2010)

Residencies

  • Neurology; University of Chicago Medicine Mitchell Hospital-Hyde Park (2018)

Fellowships

  • Neuro-Oncology; Johns Hopkins University School of Medicine (2021)
  • Neuro-Oncology; National Institutes of Health (2021)

Board Certifications

  • American Board of Psychiatry And Neurology (Neurology) (2018)

Research & Publications

Research Summary

I have a special interest in interfacing clinical outcomes and multimodality radiographic biomarkers using automated processing methods and machine learning and integrating these into the brain metastasis clinic. I am working on the development of quantitative PK/PD imaging methods and ways to translate and incorporate these into future clinical trials. It is my mission to ensure recruitment and retention of underrepresented patient populations into clinical trials.

Selected Publications

View all on PubMed

Estephan F, Ye X, Dzaye O, Wagner-Johnston N, Swinnen L, Gladstone DE, Ambinder R, Kamson DO, Lambrecht S, Grossman SA. White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab. J Neurooncol. 2019;145(3):461– 6.

Komáromy H, Mingchen. H, Perlaki G, Orsi G, Nagy SA, Bosnyák E, Kamson DO, John F, Trauninger A, Pfund. Z. Influence of hemispheric white matter lesions and migraine characteristics on cortical thickness and volume. J Headache Pain. 2019;20(1). 

Ranjan S, Skorupan N, Ye X, Sivakumar A, Yankulina O, Kamson DO, Grossman SA, Dzaye O, Holdhoff M. Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology. Neuro-Oncol Pract. 2020;7(1):52–8.

Khalafallah AM, Jimenez AE, Romo CG, Kamson DO, Kleinberg L, Weingart J, Brem H, Grossman SA, Mukherjee D. Quantifying the utility of a multidisciplinary neuro-oncology tumor board. J Neurosurg. 2020;1(aop):1–6.

Dresser L, Yuen CA, Wilmington A, Walker M, Vogel TJ, Merrell RT, Kamson DO. Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis. Sci Rep. 2020 Oct 21;10(1):17960.

Is this you? Edit Profile
back to top button